DR. MICHELLE DIAZ O.D.
Prescription History 1699778621
Optometrist in Kittery, ME
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MICHELLE DIAZ O.D., an active Optometrist specialist practicing in Kittery, ME. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 155 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 50 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other ME PrescribersVs. ME Avg |
|---|---|---|---|
| Latanoprost | 50 | $12.45▼ below ME avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 50 Medicare prescriptions for Latanoprost, about half the volume of the typical Maine prescriber of this medication (104.7). Medicare paid an average of $12.45 per fill, versus $14.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 113.8 30-Day Fills standardized to 30-day supplies 3,409 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 29 | $10.29▼ below ME avg | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 29 Medicare prescriptions for Timolol Maleate, about half the volume of the typical Maine prescriber of this medication (56.4). Medicare paid an average of $10.29 per fill, versus $18.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 68.3 30-Day Fills standardized to 30-day supplies 1,969 Days of Medication total across all patients in 2024 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $42.09▼ below ME avg | ▼ Less than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 16 Medicare prescriptions for Tobramycin-Dexamethasone, about half the volume of the typical Maine prescriber of this medication (28.6). Medicare paid an average of $42.09 per fill, versus $42.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 16 30-Day Fills standardized to 30-day supplies 207 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 14 | $46.57 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 14 Medicare prescriptions for Prednisolone Acetate, about 11% of the volume of the typical Maine prescriber of this medication (129.5). Medicare paid an average of $46.57 per fill, versus $40.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.8 30-Day Fills standardized to 30-day supplies 398 Days of Medication total across all patients in 2024 | |||
| Loteprednol Etabonate | 13 | $135.06▼ below ME avg | ▼ Less than typical |
About Loteprednol Etabonate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ It is also used after eye surgery. Loteprednol works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2024, this provider wrote 13 Medicare prescriptions for Loteprednol Etabonate, about half the volume of the typical Maine prescriber of this medication (21.9). Medicare paid an average of $135.06 per fill, versus $158.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 17.8 30-Day Fills standardized to 30-day supplies 303 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $171.10 | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. In 2024, this provider wrote 11 Medicare prescriptions for Brimonidine Tartrate-Timolol, about half the volume of the typical Maine prescriber of this medication (22). Medicare paid an average of $171.10 per fill, versus $151.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23.3 30-Day Fills standardized to 30-day supplies 700 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 11 | $1,187.75▼ below ME avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 11 Medicare prescriptions for Restasis, about a third of the volume of the typical Maine prescriber of this medication (32.2). Medicare paid an average of $1,187.75 per fill, versus $1,286.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 21 30-Day Fills standardized to 30-day supplies 615 Days of Medication total across all patients in 2024 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $242.08▼ below ME avg | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2024, this provider wrote 11 Medicare prescriptions for Simbrinza, about half the volume of the typical Maine prescriber of this medication (21.8). Medicare paid an average of $242.08 per fill, versus $265.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 21.1 30-Day Fills standardized to 30-day supplies 632 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. MICHELLE DIAZ O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Kittery, ME practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among ME prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
